Product Information
CETIRIZINE HCL 1 MG/ML SOLN is a generic product labeled by PAI Holdings LLC, priced at $0.1199 per ML under NDC 00121087416. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Jun 18, 2008. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/mL
Manufacturer
PAI Holdings LLCNDC
00121087416
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078412FDA Approved
6/18/2008
TE Code
AA
On Market Since
2/12/2024
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 1 MG/ML SOLN has been published 116 times since Jul 17, 2024, and over the history we have for it it has risen 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1199 per ML |
|---|---|
| All-time high | $0.1469 (Aug 13, 2025) |
| All-time low | $0.1129 (Jul 17, 2024) |
| 52-week high | $0.1441 |
| 52-week low | $0.1199 |
| Median price | $0.1341 |
| Average price | $0.1346 |
| Largest weekly change | -16.3% (Sep 23, 2026) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 81% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cetirizine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 1 MG/ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 1 MG/ML SOLN, manufactured by PAI Holdings LLC, is $0.1199 per ML (NDC 00121087416), effective Sep 30, 2026.
How has the price of CETIRIZINE HCL 1 MG/ML SOLN changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 1 MG/ML SOLN has risen 6.2%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 1 MG/ML SOLN?
Since Jul 17, 2024, the NADAC for CETIRIZINE HCL 1 MG/ML SOLN has ranged from a low of $0.1129 (Jul 17, 2024) to a high of $0.1469 (Aug 13, 2025), with a median of $0.1341 per ML.
Are there cheaper alternatives to CETIRIZINE HCL 1 MG/ML SOLN?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CETIRIZINE HCL 1 MG/ML SOLN, is $0.0223 per ML — about 81% below CETIRIZINE HCL 1 MG/ML SOLN.
Who manufactures CETIRIZINE HCL 1 MG/ML SOLN?
CETIRIZINE HCL 1 MG/ML SOLN (NDC 00121087416) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.